Across TCGA pan-cancer cohorts, ZNF72P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of ZNF72P’s most consistent transcriptional readouts.
The strongest signal is observed in esophageal carcinoma (ESCA), where ZNF72P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF72P is over-expressed in tumor.
ESCA are the cancer types where ZNF72P tumor–normal differential expression is most reproducible.